1Yao JC, Hassan M, Phan A, et al. One hundred years after "carci-noid": Epidemiology of and prognostic factors for neuroendocrinetumors in 35 825 cases in the united states [J]. J Clin Oncol, 2008,26(18):3063-3072.
2Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13 715 carci-noid tumors [J]. Cancer, 2003,97(4):934-959.
3Ito T, Sasano H, Tanaka M, et al. Epidemiological study of gas-troenteropancreatic neuroendocrine tumors in Japan [J]. J Gastroen-terol, 2010,45(2):234-243.
4Lim T, Lee J, Kim JJ, et al. Gastroenteropancreatic neuroendocrinetumors: Incidence and treatment outcome in a single institution inKorea[J]. Asia Pac J Clin Oncol, 2011,7(3):293-299.
5Lawrence B, Gustafsson BI, Chan A, et al. The epidemiology of gas-troenteropancreatic neuroendocrine tumors [J]. Endocrinol Metab ClinNorth Am, 2011,40(1):1-18, vii.
6Rindi G, Kloppel G, Couvelard A, et al. TNM staging of midgut andhindgut (neuro) endocrine tumors: A consensus proposal includinga grading system [J]. Virchows Archiv, 2007,451 (4):757-762.
7Avihingsanon A, Tongkobpetch S, Kerr SJ, et al. Pharmacogenetictesting can identify patients taking atazanavir at risk for hyper-bilirubinaemia[J]. J Acquir Immune Defic Syndr, 2015,69(l):e36-e37.
8Bemick PE, Klimstra DS, Shia J, et al. Neuroendocrine carcinomasof the colon and rectum[J]. Dis Colon Rectum, 2004,47(2):163-169.
9Glancy DG, Pullyblank AM, Thomas MG. The role of colonoscopicendoanal ultrasound scanning (EUS) in selecting patients suitablefor resection by transanal endoscopic microsurgery (TEM) [J]. Col-orectal Dis, 2005,7(2):148-150.
10Shinji S, Naito Z, Ishiwata T, et al. Neuroendocrine cell differenti-ation of poorly differentiated colorectal adenocarcinoma correlateswith liver metastasis[J]. Int J Oncol, 2006,29(2):357-364.
